Lirucitinib
Lirucitinib is a small molecule JAK inhibitor utilized in research for its anti-inflammatory effects. It is employed in both in vitro and in vivo studies to investigate JAK/STAT signaling pathways in immunological and inflammatory disease models.
Product Specifications
CAS Number
2458115-78-9
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Smiles
N (C) (C1=C2C (NC=C2) =NC=N1) [C@@H]3CC[C@@H] (CS (CC) (=N) =O) CC3
Molecular Formula
C16H25N5OS
Molecular Weight
335.468
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PB9883-Cy3 100 µg/Vial
Anti-RAB7/RAB7A Antibody Picoband® (Cy3 Conjugate)
Sign In for Pricing
View Details 056920-01 10 µg
SMAD family member 6 (SMAD6), Recombinant, Rat, His-Tag
Sign In for Pricing
View Details 056920-02 50 µg
SMAD family member 6 (SMAD6), Recombinant, Rat, His-Tag
Sign In for Pricing
View Details 056920-03 100 µg
SMAD family member 6 (SMAD6), Recombinant, Rat, His-Tag
Sign In for Pricing
View Details 056920-04 200 µg
SMAD family member 6 (SMAD6), Recombinant, Rat, His-Tag
Sign In for Pricing
View Details MBS1251254-01 0.05 mg (E-Coli)
Recombinant Conus obscurus Alpha-conotoxin OIVB
Sign In for Pricing
View Details